Table of contents
About this book
This book explores the possible development of neurokinin-3 receptor (NK3R) antagonists with reduced environmental impact.
Pharmaceuticals are used to cure diseases and to alleviate symptoms in humans and animals. However, the stable, bioactive substances excreted by patients have unfavorable effects on non-target species. To overcome these disadvantages of these highly stable, potent substances, drug design to turn off bioactivity after release into the environment is needed.
The book describes the development of eco-friendly NK3R antagonists by introducing a labile functional moiety and substituting a scaffold. This resulted in a novel NK3R antagonist that oxidized into its inactive form when exposed to air. Further, the book presents an efficient and easily achievable synthetic method of creating triazolopiperazine scaffolds, as well as a structure–activity relationship study involving scaffold hopping for decomposable motifs, which led to a novel photodegradable NK3R antagonist.
Drug Design with Reduced Environmental Impact Structure–activity Relationship Study Neurokinin-3 Receptor Antagonist NK3R Reproductive Disorder Agents
- DOI https://doi.org/10.1007/978-981-15-2965-8
- Copyright Information Springer Nature Singapore Pte Ltd. 2020
- Publisher Name Springer, Singapore
- eBook Packages Chemistry and Materials Science
- Print ISBN 978-981-15-2964-1
- Online ISBN 978-981-15-2965-8
- Series Print ISSN 2190-5053
- Series Online ISSN 2190-5061
- Buy this book on publisher's site